19-15471932-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_052890.4(PGLYRP2):​c.1301G>T​(p.Arg434Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,614,118 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.00028 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

PGLYRP2
NM_052890.4 missense

Scores

1
6
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.73
Variant links:
Genes affected
PGLYRP2 (HGNC:30013): (peptidoglycan recognition protein 2) This gene encodes a peptidoglycan recognition protein, which belongs to the N-acetylmuramoyl-L-alanine amidase 2 family. This protein hydrolyzes the link between N-acetylmuramoyl residues and L-amino acid residues in bacterial cell wall glycopeptides, and thus may play a scavenger role by digesting biologically active peptidoglycan into biologically inactive fragments. [provided by RefSeq, Sep 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.19389495).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PGLYRP2NM_052890.4 linkuse as main transcriptc.1301G>T p.Arg434Leu missense_variant 3/5 ENST00000340880.5 NP_443122.3 Q96PD5-1
PGLYRP2NM_001363546.1 linkuse as main transcriptc.1301G>T p.Arg434Leu missense_variant 3/4 NP_001350475.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PGLYRP2ENST00000340880.5 linkuse as main transcriptc.1301G>T p.Arg434Leu missense_variant 3/51 NM_052890.4 ENSP00000345968.4 Q96PD5-1
PGLYRP2ENST00000292609.8 linkuse as main transcriptc.1301G>T p.Arg434Leu missense_variant 3/41 ENSP00000292609.3 Q96PD5-2

Frequencies

GnomAD3 genomes
AF:
0.000282
AC:
43
AN:
152258
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000981
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000382
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000187
AC:
47
AN:
250738
Hom.:
0
AF XY:
0.000206
AC XY:
28
AN XY:
135656
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000289
Gnomad ASJ exome
AF:
0.0000995
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.000196
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000239
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.000130
AC:
190
AN:
1461742
Hom.:
0
Cov.:
32
AF XY:
0.000138
AC XY:
100
AN XY:
727192
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000313
Gnomad4 ASJ exome
AF:
0.0000766
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000928
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000139
Gnomad4 OTH exome
AF:
0.000166
GnomAD4 genome
AF:
0.000282
AC:
43
AN:
152376
Hom.:
0
Cov.:
33
AF XY:
0.000349
AC XY:
26
AN XY:
74506
show subpopulations
Gnomad4 AFR
AF:
0.0000240
Gnomad4 AMR
AF:
0.000980
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000382
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000659
Hom.:
0
Bravo
AF:
0.000280
ExAC
AF:
0.000181
AC:
22
EpiCase
AF:
0.000218
EpiControl
AF:
0.000415

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 04, 2024The c.1301G>T (p.R434L) alteration is located in exon 3 (coding exon 3) of the PGLYRP2 gene. This alteration results from a G to T substitution at nucleotide position 1301, causing the arginine (R) at amino acid position 434 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.18
.;T
Eigen
Benign
0.064
Eigen_PC
Benign
0.078
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.80
T;T
M_CAP
Benign
0.043
D
MetaRNN
Benign
0.19
T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Uncertain
2.8
M;M
PrimateAI
Uncertain
0.50
T
PROVEAN
Pathogenic
-4.7
D;D
REVEL
Benign
0.17
Sift
Uncertain
0.013
D;D
Sift4G
Uncertain
0.022
D;D
Polyphen
0.30
B;B
Vest4
0.39
MVP
0.53
MPC
0.99
ClinPred
0.61
D
GERP RS
2.3
Varity_R
0.30
gMVP
0.83

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139692091; hg19: chr19-15582743; API